Thank you for attending the 2025 National PH Medical Think Tank!
Your feedback is vital in helping us improve future events and ensure we continue to provide relevant, engaging, and impactful programming for the PH community.
​
Please take a few minutes to complete the evaluations below.

Session Evaluations​
​
To give us feedback on specific sessions, simply click the links below. Please complete evaluations for each session you attended.
Thursday:
​
Female sex and pulmonary hypertension
Dr. Steven Kawut, University of Pennsylvania
Why is my patient short of breath? Mechanisms of residual dyspnea post pulmonary embolism
Dr. Devin Phillips, York University
Updates from the Canadian Pulmonary Hypertension Registry
Dr. Nathan Brunner, University of British Columbia; Freda Tom
Biomarkers in pulmonary hypertension
Dr. Athénaïs Boucly, Université Paris-Saclay
Pulmonary veno-occlusive disease
Dr. Duncan J. Stewart, University of Ottawa Heart Institute
Inflammatory mechanisms in pulmonary arterial hypertension – basic and translational approaches
Dr. Neil Goldenberg, University of Toronto
The importance of blood vessels in the progression of pulmonary fibrosis
Dr. Martin Kolb, McMaster University
Friday Morning:
Keynote: Big data in pulmonary hypertension: Looking backward and forward
Dr. Steven Kawut, University of Pennsylvania
Anti-remodeling agents in PAH: A double-edged sword
Dr. Sébastien Bonnet, Université Laval
Pulmonary hypertension: What’s in a name?
Dr. George Chandy, University of Ottawa Heart Institute
Hemodynamic phenotyping of pulmonary hypertension
Dr. Susanna Mak, University of Toronto
Pulmonary capillary recruitment: a way of life
Dr. David Langleben, McGill University
Assessment of right ventricular function in pediatric pulmonary hypertension
Dr. Mark Friedberg, Hospital for Sick Children
​
Friday Afternoon:
Setting treatment goals: an evidence-based and personalized approach
Dr. Jason Weatherald, University of Alberta
Treatment strategies for Group 1 pulmonary hypertension
Dr. Sanjay Mehta, Western University
Keynote: Understanding heterogeneity of treatment effects
Dr. Athénaïs Boucly, Université Paris-Saclay
Topics in Group 3 pulmonary hypertension
Dr. Sarah MacIsaac, Dalhousie University
Interactive case study in acute RV failure
Dr. John Granton, University Health Network
What lies ahead?
Dr. Steeve Provencher, Université Laval ​
Why Your Feedback Matters​
​
Your feedback helps us make the Think Tank stronger each year. By sharing your thoughts, you guide us in refining session topics and formats, improving the experience for both in-person and virtual attendees, and providing meaningful input to our speakers and organizers. Most importantly, your reflections shape the future of PH knowledge exchange in Canada.
​
Thank you for taking the time to share your thoughts and helping us drive change and inspire hope!

